Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MoCHA: Caffeine Citrate in Preterm Infants
NCT03340727Phase 3Terminated
- Sponsor
- NICHD Neonatal Research Network
- Start
- Feb 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caffeine in apnea of prematurity (AOP), sponsored by NICHD Neonatal Research Network. Started Feb 2019; status: terminated.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT03340727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340727.